Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung CancerValsamo Anagnostou, Victor E. Velculescu, William H. Sharfman et al.|Cancer Discovery|2016Cited by 897
Primary Renal Neoplasms with the ASPL-TFE3 Gene Fusion of Alveolar Soft Part SarcomaPedram Argani, Marc Ladanyi, Cristina R. Antonescu et al.|American Journal Of Pathology|2001Cited by 639
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)Tricia R. Cottrell, Janis M. Taube, Elizabeth D. Thompson et al.|Annals of Oncology|2018Cited by 588
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancersJustina X. Caushi, Kellie N. Smith, Taha Merghoub et al.|Nature|2021Cited by 546
Detection of Transcriptionally Active High-risk HPV in Patients With Head and Neck Squamous Cell Carcinoma as Visualized by a Novel E6/E7 mRNA In Situ Hybridization MethodJustin A. Bishop, William H. Westra, Xiao-Jun Ma et al.|The American Journal of Surgical Pathology|2012Cited by 344